Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Depreciation & Amortization (CF): 2019-2024

Historic Depreciation & Amortization (CF) for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to $20.9 million.

  • Maravai Lifesciences Holdings' Depreciation & Amortization (CF) rose 18.46% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.1 million, marking a year-over-year increase of 19.77%. This contributed to the annual value of $20.9 million for FY2024, which is 62.02% up from last year.
  • Maravai Lifesciences Holdings' Depreciation & Amortization (CF) amounted to $20.9 million in FY2024, which was up 62.02% from $12.9 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Depreciation & Amortization (CF) registered a high of $20.9 million during FY2024, and its lowest value of $5.6 million during FY2020.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Depreciation & Amortization (CF) value was $12.9 million (recorded in 2023), while the average stood at $13.8 million.
  • Data for Maravai Lifesciences Holdings' Depreciation & Amortization (CF) shows a peak YoY soared of 69.74% (in 2023) over the last 5 years.
  • Over the past 5 years, Maravai Lifesciences Holdings' Depreciation & Amortization (CF) (Yearly) stood at $5.6 million in 2020, then grew by 14.52% to $6.4 million in 2021, then grew by 18.51% to $7.6 million in 2022, then skyrocketed by 69.74% to $12.9 million in 2023, then spiked by 62.02% to $20.9 million in 2024.